Molecular Partners AG (MOLN) Stock Price, Quote, News & History

MOLNNASDAQ
$4.30
At close: Sep 25, 5:00 PM EST
$4.67
0.378.6%
After Hours: Aug 28, 4:43 AM EST

Molecular Partners (MOLN) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-46.11M
Investing Cash Flow (TTM)
33.09M
Financing Cash Flow (TTM)
-1.11M
Free Cash Flow (TTM)
-46.30M
Capital Expenditure (TTM)
-190.00K
Net Change in Cash (TTM)
-14.13M

Analyst Trends and Forecast

1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$70.58M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.31
Earnings Yield % (TTM)
-38.24%
Earnings Yield % (FWD)
-37.68%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.86

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$1.21M
Total Cash
$67.93M
Debt to Equity
0.05
Issuance of Debt (TTM)
-$1.21M
Repayment of Debt (TTM)
-$1.21M

Key Statistics

Open
-
Close
-
Volume / Avg.
40.00 / 3.84K
Day Range
- - -
52 Wk Range
3.53 - 5.36
Market Cap
$174.65M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeuti...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Molecular Partners (MOLN) stock?

A

You can purchase shares of Molecular Partners (NASDAQ:MOLN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Molecular Partners (MOLN) competitors?

Q

What is the forecast, or price target, for Molecular Partners (MOLN) stock?

A

Molecular Partners has a consensus price target of $9.58.

Q

What is the current price for Molecular Partners (MOLN)?

A

The stock price for Molecular Partners (NASDAQ: MOLN) is $4.67 last updated August 28, 2026 at 4:43 AM EDT.

Q

Does Molecular Partners (MOLN) pay a dividend?

A

There are no upcoming dividends for Molecular Partners.

Q

When is Molecular Partners (NASDAQ:MOLN) reporting earnings?

A

Molecular Partners does not have any upcoming earnings scheduled.

Q

Is Molecular Partners (MOLN) going to split?

A

There is no upcoming split for Molecular Partners.

Q

What sector and industry does Molecular Partners (MOLN) operate in?

A

Molecular Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.